Thanks Rebel, nice to see someone with a little fire in their gut and maybe get a decent discussion going. I know CLL is above last years price, not by much though. I really don't think CLL would be scrambling for financing. If CLL waited until approval came then it might have taken a few months to secure financing. The wasted interest in the past year would be money in the bank instead of an expense gone out the door. DG has made some great moves but I think he blew it on the financing one. Here's a question, would you rather spend $30 million in interest, just to be comfortable, or wait for approval then work or "scramble"as you call it for financing once you have secured the next approval. If the "scramble" took 2 months, would 2 months of Algar production make up $30 million, remember also that when they secured financing they paid a penalty of $ 1.6 million to pay off debt, another waste. So if you think I'm an idiot because I think he blew it on the financing part then go ahead. I put my money where my mouth is. I sold some at $5.18, tried to sell some more at $5.30 but it didn't hit. As Kramer would do I have been buying again once it hit $4.90 and all along down. I have been buying because I see this as a $6.75 stock by August. Even with the financing farce.